abnormals

Related by string. abnormal * * abnormal Pap smears . abnormal electrical impulses . abnormal uterine bleeding . abnormal thickening . abnormal prions . abnormal prion protein . abnormal hemoglobin . abnormal gait . abnormal clumps . abnormal heartbeat . abnormal heartbeats . abnormal mammogram . abnormal mammograms . abnormal lipid . abnormal Pap test . abnormal curvature *

Related by context. Frequent words. (Click for all words.) 56 goodwill amortization 54 exceptionals 54 NPAT 50 amortization EBITA 49 EBITA 48 EBIT 48 NZ#.# [004] 48 pretax profit 47 ebitda 47 pretax 47 profit 47 pretax profits 46 earnings 46 Futuris 45 Pretax 45 reinstatement premiums 45 depreciation amortization 45 A#m [002] 44 Headline earnings 44 property revaluations 44 non recurring 43 £ #.#m [004] 43 diluted EPS 43 impairment charges 43 FY pretax 43 writedowns 43 Non GAAP EPS 43 doubtful debts 42 US#.#bn [004] 42 £ #.#bn [005] 42 Excluding discontinued operations 42 EUR -#.# [003] 42 fully franked dividend 42 items affecting comparability 42 nonrecurring items 42 R#.#m [007] 42 HEPS 42 EBIDTA 42 EPS 41 Ebit 41 Earnings 41 NZ# [002] 41 #,# c [003] 41 asset disposals 41 underlying pretax 41 depreciation 41 pcp 41 cashflows 41 GAAP EPS 41 goodwill impairments 41 pro forma 41 intangibles amortization 41 amortization EBITDA 41 write downs 41 US#.# [005] 41 aftertax 40 NZ#.# [005] 40 cashflow 40 net 40 #.#ma [001] 40 writedown 40 profits 40 GBP#.# [005] 40 £ #.#bn [007] 40 US#c [002] 40 FY# [001] 40 proforma 40 Australand 40 items impacting comparability 40 Pretax profit 40 GBP#.#m [004] 40 adjusted EPS 39 nonrecurring 39 goodwill impairment charge 39 EBITDA 39 interim dividend 39 Incitec Pivot 39 Unallocated corporate 39 EBITA margin 39 Diluted EPS 39 Incitec 39 £ #.#ma [003] 39 Profit 39 distributable 39 Forsyth Barr 39 mln aud 39 EBIT margin 39 Goldman Sachs JBWere 39 A#.# [007] 39 Y#.# billion [002] 39 aA 39 NZ# [001] 39 Baycorp 39 SEK#.# billion [001] 39 £ #.#m [006] 38 adjusted EBIT 38 writeoffs 38 adjusted EBITDA 38 pro forma EBITDA 38 proforma basis 38 disposals

Back to home page